Solid leadership is critical to the success of a world-class institution like Joslin.
Joslin's Board of Trustees is made up of local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of a future without diabetes.
Joslin's Board of Trustees works closely with the Joslin executive staff. Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge — the hallmark of this one-of-a-kind Center.
Jessica Hopfield, Ph.D., is a former partner of McKinsey & Company in their Global Pharmaceutical and Medical Device practice. While at McKinsey from 1995-2009, she served clients across pharmaceutical, biotech, medical device and consumer industries with a focus on strategy, R&D management and marketing. [more]
Ann Lagasse is Principal, Ocean Havens LLC. Ann and her husband Chuck founded Ocean Havens LLC a real estate company that focuses on marina and upland acquisition, development and management, in 2007. The company has created exciting destinations for yachting in New England including Boston Yacht Haven Inn & Marina, Charlestown Marina, Fan Pier Marina, Boston Harbor Shipyard & Marina and Provincetown Marina. [more]
John J. Cook, Jr., Counsel, Seaward Management. John joined Seaward in March 1999 and was a Managing Director through 2013. Prior to this he was President of UAM Investment Services for five years. [more]
Mike Devlin currently serves as Executive Vice President and Chief Financial Officer of Randolph Bancorp, Inc. and its wholly-owned subsidiary, Randolph Savings Bank. In this role, he leads all of the Bank’s financial activities, including financial reporting and budgeting, as well as asset-liability, investment portfolio and risk management. [more]
Roberta Herman M.D. was, until July 2013, was the Chief Operating Officer for Harvard Pilgrim Health Care, one of New England’s largest non-profit managed health care organizations, providing care and coverage to over one million members throughout Massachusetts, Maine, and New Hampshire. [more]
Fred Keeton is widely respected for his knowledge and business acumen, and he is a noted and sought after speaker. Keeton articulates the requirement for inclusion driven business enhancement and provides passionate leadership. Fred's veteran business and corporate relations experience allows him to effectively address dynamic and highly challenging issues in our ever changing political, social and economic environment. [more]
Daniel R. Omstead, Ph.D., is Chief Executive Officer of Tekla Capital Management LLC and President and Portfolio Manager of Tekla Healthcare Investors, Tekla Life Science Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund; four NYSE listed closed-end mutual funds that make equity investments in healthcare-related companies. [more]
James Peterson served as CEO of Haemonetics Corporation, and after retirement has worked to bring new technologies into reality to improve the quality of life of people with diabetes. In the process he was advisor to a private equity group on their diabetes investments, founded an insulin pump company for people with type 1 diabetes, and founded an insulin infusion company for people with type 2 diabetes. [more]
Geoffrey S. Rehnert is the Co-Chief Executive Officer and co-founder of Audax Group, a leading middle market private equity and private debt firm. Prior to founding Audax Group, Mr. Rehnert was a General Partner and Managing Director of Bain Capital, Inc., which he helped to start in 1984. [more]
Arthur H. Rubenstein, MBBCh is Professor, Department of Medicine, Division of Endocrinology at the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania. Previously, Dr. Rubenstein was the Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Raymond and Ruth Perelman School of Medicine from September 2001 to July 2011. [more]
Mark E. Russell is Vice President of Engineering, Technology and Mission Assurance for Raytheon Company. He assumed the position in July 2008, and was elected a company officer in June 2008. Russell guides the company’s vision and provides corporate leadership in the strategic areas of technology and research, engineering, operations, performance excellence, programs security, Raytheon Six Sigma™ and Mission Assurance. He is responsible for 45,000 world-class people working on more than 8,000 programs. [more]
Stefany Shaheen is the Chief Operating Officer of Good Measures, a provider of Registered Dietitian Nutritionist (RDN) services. Prior to Good Measures, Shaheen owned and operated a management and communications consulting practice working with private and non-profit organizations with a focus on helping organizations navigate challenging transitions. [more]
Richard Smith is the Co-Chairman of the Richard and Susan Smith Family Foundation. Dick has held a wide range of influential business and civic positions over the course of his career. He was the former Chairman of the Board and CEO of Harcourt General, the Neiman Marcus Group and the GC Companies. He has held directorships at the First National Bank of Boston, Liberty Mutual Insurance Company and Wang Laboratories. [more]
Robert A. Gabbay, M.D., Ph.D., FACP, Chief Medical Officer, has over 35 years of clinical and research experience and is Chief Medical Officer and Senior Vice President at Joslin Diabetes Center. [more]
Ken Quickel, M.D. is President Emeritus of the Joslin Diabetes Center. He served as CEO from 1987-2000 and again from 2008-2010. He was a staff physician at Beth Israel Deaconess Medical Center, a lecturer at Harvard Medical School, a trustee of both Beth Israel Deaconess Medical Center and CareGroup and an Overseer of Brigham & Women’s Hospital. [more]
Page last updated: May 24, 2019